| MeSH term | MeSH ID | Detail |
|---|---|---|
| Glomerulonephritis, Membranous | D015433 | 6 associated lipids |
| Weight Loss | D015431 | 56 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Myocardial Reperfusion Injury | D015428 | 20 associated lipids |
| Reperfusion Injury | D015427 | 65 associated lipids |
| Zellweger Syndrome | D015211 | 39 associated lipids |
| Wounds and Injuries | D014947 | 20 associated lipids |
| Weil Disease | D014895 | 2 associated lipids |
| Granulomatosis with Polyangiitis | D014890 | 5 associated lipids |
| Vitamin E Deficiency | D014811 | 29 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lowenstein E and Zapol WM | Protamine reactions, explosive mediator release, and pulmonary vasoconstriction. | 1990 | Anesthesiology | pmid:2393123 |
| Morel DR et al. | Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent. | 1990 | Anesthesiology | pmid:2098007 |
| Hirakata H et al. | Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity. | 1996 | Anesthesiology | pmid:8968193 |
| Shayevitz JR et al. | Inhalation anesthetics augment oxidant-induced pulmonary vasoconstriction: evidence for a membrane effect. | 1985 | Anesthesiology | pmid:3933385 |
| Munsterhjelm E et al. | Dose-dependent inhibition of platelet function by acetaminophen in healthy volunteers. | 2005 | Anesthesiology | pmid:16192763 |
| Horiguchi T et al. | Heparin-protamine complexes cause pulmonary hypertension in goats. | 1995 | Anesthesiology | pmid:7574058 |
| Hirakata H et al. | Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro. | 1999 | Anesthesiology | pmid:10551587 |
| Heller A et al. | Pancreatitis-associated protein protects the lung from leukocyte-induced injury. | 1999 | Anesthesiology | pmid:10551593 |
| Fratacci MD et al. | Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. | 1991 | Anesthesiology | pmid:1741521 |
| Kurrek MM et al. | Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb. | 1995 | Anesthesiology | pmid:7832299 |
| Numano F et al. | Antiaggregative aspirin dosage at the affected vessel wall. | 1986 | Angiology | pmid:2876664 |
| Bölke E et al. | Changes of gut barrier function during anesthesia and cardiac surgery. | 2001 | Angiology | pmid:11515987 |
| Mikhailidis DP et al. | Platelet function in patients admitted with a diagnosis of myocardial infarction. | 1987 | Angiology | pmid:2880535 |
| Vissinger H et al. | Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid. | 1993 | Angiology | pmid:8342880 |
| Saitta A et al. | Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery disease. | 1998 | Angiology | pmid:9822043 |
| Jean T and Bodinier MC | Mediators involved in inflammation: effects of Daflon 500 mg on their release. | 1994 | Angiology | pmid:8203787 |
| Nichols WW et al. | Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist. | 1989 | Angiology | pmid:2537051 |
| Sinzinger H et al. | Platelet half-life, plasma thromboxane B2 and circulating endothelial-cells in peripheral vascular disease. | 1986 | Angiology | pmid:3954150 |
| Nagano H et al. | Cerebral microcirculatory changes after cerebral embolization induced by glass bead injection in rabbits. | 1992 | Angiology | pmid:1632571 |
| Takase B et al. | Arachidonic acid metabolites in acute myocardial infarction. | 1996 | Angiology | pmid:8686958 |
| Oda H et al. | Alcohol and coronary spasm. | 1994 | Angiology | pmid:8129199 |
| Kurita A et al. | The effects of orally administered atenolol on the coronary hemodynamics and prostaglandin metabolism in angina pectoris patients. | 1994 | Angiology | pmid:8129203 |
| Fujinishi A et al. | Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease. | 1997 | Angiology | pmid:9194537 |
| Nishikata H et al. | Induction of bronchial hyperresponsiveness by Bordetella bronchiseptica infection in dogs. | 1989 | Ann Allergy | pmid:2643371 |
| Kivioja A et al. | Platelet activation during acute phase after multiple trauma. | 1992 | Ann Chir Gynaecol | pmid:1456710 |
| Lin TY et al. | The effect of YAG laser anterior capsulotomy on prostaglandin concentration in aqueous humor. | 1988 | Ann Ophthalmol | pmid:3400958 |
| Mohri H and Ohkubo T | Single-dose effect of enteric-coated aspirin on platelet function and thromboxane generation in middle-aged men. | 1993 | Ann Pharmacother | pmid:8477113 |
| Tanen DA et al. | Comparison of oral aspirin versus topical applied methyl salicylate for platelet inhibition. | 2008 | Ann Pharmacother | pmid:18698012 |
| Angel MF et al. | The effect of prior elevation of skin flaps and ischemia on blood thromboxane levels. | 1989 | Ann Plast Surg | pmid:2751221 |
| Edstrom LE et al. | Effect of ischemic skin flap elevation on tissue and plasma thromboxane A2 and prostacyclin production: modification by thromboxane synthetase inhibition. | 1988 | Ann Plast Surg | pmid:3281544 |
| Paterson IS et al. | Reperfusion plasma contains a neutrophil activator. | 1993 | Ann Vasc Surg | pmid:8390848 |
| Ascer E et al. | Interleukin-1 and thromboxane release after skeletal muscle ischemia and reperfusion. | 1992 | Ann Vasc Surg | pmid:1547081 |
| Fukushima C et al. | In vitro responses to antigen stimulation: comparison between human lung parenchyma resected from asthmatic patients and non-asthmatic patients. | 1999 | Ann. Allergy Asthma Immunol. | pmid:10071522 |
| Zhao Y et al. | Effect of a Chinese herbal formula, Shi-Bi-Lin, on an experimental model of allergic rhinitis. | 2006 | Ann. Allergy Asthma Immunol. | pmid:16802773 |
| Fukushima C et al. | Effect of synthetase inhibitors and receptor antagonists in antigen-induced contraction of human lung parenchyma. | 1998 | Ann. Allergy Asthma Immunol. | pmid:9532973 |
| Takao A et al. | Inhibitory effects of azelastine hydrochloride in alcohol-induced asthma. | 1999 | Ann. Allergy Asthma Immunol. | pmid:10227338 |
| Fukushima C et al. | Inhibitory effect of thromboxane A2 synthetase inhibitor, DP-1904, on antigen-induced contraction of human lung parenchyma. | 1996 | Ann. Allergy Asthma Immunol. | pmid:8970439 |
| Morris RH and Davies GG | Thin layer chromatographic identification of thromboxane B2 in serum, and platelet rich plasma stimulated by arachidonic acid and collagen. | 1993 | Ann. Clin. Biochem. | pmid:8466155 |
| Nordøy A | Lipids and thrombogenesis. | 1981 | Ann. Clin. Res. | pmid:7018362 |
| Ylikorkala O | Prostanoids in gynaecology. | 1984 | Ann. Clin. Res. | pmid:6398666 |
| Vapaatalo H et al. | Prostanoids in blood pressure regulation and their role in the blood pressure lowering effects induced by changes in dietary fats. | 1984 | Ann. Clin. Res. | pmid:6398981 |
| Elias M et al. | Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue. | 1992 | Ann. Hematol. | pmid:1379080 |
| Lee M et al. | Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury. | 1994 | Ann. Intern. Med. | pmid:8273981 |
| Whelton A et al. | Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison. | 1990 | Ann. Intern. Med. | pmid:2183665 |
| Emanuelli G et al. | [Effects of anti-adrenergic drugs on thrombin-induced platelet aggregation and thromboxane B2 production]. | 1988 Oct-Dec | Ann. Ital. Med. Int. | pmid:3275193 |
| Osterud B and Hansen JB | Fatty acids, platelets and monocytes. Something to do with atherogenesis. | 1989 | Ann. Med. | pmid:2923703 |
| Panganamala RV and Cornwell DG | The effects of vitamin E on arachidonic acid metabolism. | 1982 | Ann. N. Y. Acad. Sci. | pmid:6816121 |
| Jesse RL et al. | Dehydroepiandrosterone inhibits human platelet aggregation in vitro and in vivo. | 1995 | Ann. N. Y. Acad. Sci. | pmid:8597466 |
| Takami M et al. | Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma. | 1991 | Ann. N. Y. Acad. Sci. | pmid:1952565 |
| Crinnion JN et al. | Neutrophils and the endothelium in post-ischemic alterations in skeletal muscle blood flow. | 1994 | Ann. N. Y. Acad. Sci. | pmid:8030907 |